The phase III Zostavax Efficacy and Safety Trial of @ dose of licensed zoster vaccine ( ZV ; Zostavax ; Merck ) in @-@-year-olds showed approximately @ % vaccine efficacy ( VE ) to reduce the incidence of herpes zoster ( HZ ) .